Literature DB >> 6223766

Circulating T-cell subsets in Graves' disease: differences between patients with active disease and in remission after 131I-therapy.

G W Canonica, M Bagnasco, S Ferrini, P Biassoni, G Giordano, G Corte.   

Abstract

In the present investigation some surface markers in peripheral blood T lymphocytes of patients with active Graves' disease and subjects in remission after 131I-therapy have been studied. We confirmed low TG levels in untreated patients and normal values in treated subjects. Increased percentages of DR+, MLR4+ (activated T cells), and 5/9+ (inducer-helper) T cells were detected in patients with active disease, thus indicating the presence of activated T cells and suggesting increased levels of helper T cells. High percentages of MLR4+ and 5/9+, but normal levels of DR+ were found in 131I-treated subjects. The different distribution of DR and MLR4 positivities on 5/9+ and 5+9-T cells confirm the different meaning of these two markers of the activation state. The imbalance of T-cell subsets found in 131I-treated subjects and the normal values observed in patients with hyperthyroidism due to toxic adenoma indicate that hyperthyroidism per se is not sufficient to explain the T-cell alterations. The possible meaning of these findings is discussed with respect to previous hypotheses on the pathogenesis of Graves' disease.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6223766     DOI: 10.1016/0090-1229(83)90160-5

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  6 in total

1.  Immunomodulation by methimazole therapy in Graves' disease: rapid changes in activation stage of circulating regulatory T cell subsets, B cells and NK cells.

Authors:  F A Karlsson; T H Tötterman
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

2.  Incidence of T cell subset imbalance in relatives of Graves' disease patients.

Authors:  P Biassoni; G Ciprandi; S Ferrini; G Chimini; G W Canonica; M Bagnasco
Journal:  J Endocrinol Invest       Date:  1984-04       Impact factor: 4.256

3.  Analysis of T cell subsets in Graves' disease: alterations associated with carbimazole.

Authors:  M E Ludgate; A M McGregor; A P Weetman; S Ratanachaiyavong; J H Lazarus; R Hall; G W Middleton
Journal:  Br Med J (Clin Res Ed)       Date:  1984-02-18

4.  Functional characterization of a regulatory human T-cell subpopulation increasing during autologous MLR.

Authors:  M E Cosulich; A Risso; G W Canonica; A Bargellesi
Journal:  Immunology       Date:  1986-02       Impact factor: 7.397

5.  Autoimmune thyroid disease: purification and phenotypic analysis of intrathyroid T cells.

Authors:  G W Canonica; M Caria; G Torre; A Risso; M E Cosulich; M Bagnasco
Journal:  J Endocrinol Invest       Date:  1984-12       Impact factor: 4.256

6.  T cell subsets and thyroid-stimulating antibodies in patients with Graves' disease in clinical remission.

Authors:  M Bagnasco; E Macchia; G Ciprandi; M Caria; G F Fenzi
Journal:  J Endocrinol Invest       Date:  1986-06       Impact factor: 4.256

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.